Content related to Improving Long-Term Effects of Radiation in Children: A Research-Based Labor of Love

Medulloblastoma, the most common malignant brain tumor occurring in children, is a fast-growing cancer that affects nearly 2 million people – including adults – annually. Traditionally

Researchers at Children’s Hospital Los Angeles led a multi-institutional study that pins down, for the first time, the actual risk of hearing loss from cisplatin, a common chemotherapy agent

While other toddlers her age were fighting naptime, two-year-old Michelle was battling an aggressive, life-threatening cancer. Doctors at Children’s Hospital Los Angeles saved her life in an epic

Researchers have been delving deeper to better understand long-term cancer survival and quality of life for adolescent and young adult patients.

New clinic provides comprehensive screening and treatment for children with endocrine issues caused by cancer treatment.

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

Investigators at Children’s Hospital Los Angeles have found that chemotherapy-induced hearing loss may also contribute to long-term neurocognitive deficits in pediatric brain tumor survivors.